5Chayakulkeeree M,Perfect JR.Cryltococeosis[J].Infect Dis Clin N Am,2006,20 (3):507.
6Sugiura Y, Homma M,Yamamoto T.Difficulty in diagnosing chronic meningitis caused by capsule-deficient Cryptococcus neofonllans[J].J Neurol Neurosurg Psychiatry,2005,76 (10): 1460.
二级参考文献10
1Jain N,Li Li, McFadden D C, et al. Phenotypic switching in a cryptococcus neoformans variety gattii strain is asso ciated with changes in virulence and promotes dissemination to the central nervous system[J]. Infec Immun,2006, 74(2) :896.
2Guerrero A,Jain N, Goldman D L, et al. Phenotypic switching in cryptococcus neoformans[J]. Microbiology, 2006, 152(1) :3.
3Charlier C, Chretien F, Baudrimont M, et al. Capsule structure changes associated with cryptocoecus neoforroans crossing of the blood brain barrier[ J]. Am J Pathol, 2005,2 : 166.
4Chang Y C, Stins MF, McCaffery MJ, et ah Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood brain barrier[J]. Infect Immun,2004,72(9) :4985.
5Akcaglar S, Sevgican E, Akalin H, et al. Two cases of cryptococcal meningitis in immunocompromised patients not infected with HIV[J]. Mycoses,2007,50 : 235.
6Lagrou K, Van Eldere J, Keuleers S, et al. Zoonotic transmission of cryptocoeeus neoformans from a magpie to an immunocompetent patient[J]. J Intern Med, 2005,257: 385.
7Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated eryptococCal meningitis:a randomised trial [J]. Lancet, 2004,363 : 1264.
8Larsen RA,Bauer M, Thomas AM, et al. Amphoteriein B and fluconazole,a potent combination therapy for cryptococcal meningitis [J]. Antimicrob Agents Chemother, 2004,48 (3) : 985.
9Larsen RA, Pappas PG, Perfect J, et al. Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptoeoccal antibody 18137 in subjects with treated eryptoeoeeal meningitis [J]. Antimicrob Agents Chemother, 2005,49(3) :952.
10Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, et al. Cryptococcosis in human immunodeficiency virus neg ative patients[J]. Int J Infect Dis, 2006,10 : 72.
